Editorial
doi: 10.1111/apt.14687.
Editorial: an argument for low-dose thiopurine allopurinol combination use as first-line therapy in inflammatory bowel disease
Affiliations
- PMID: 29882989
- DOI: 10.1111/apt.14687
Item in Clipboard
Editorial
Editorial: an argument for low-dose thiopurine allopurinol combination use as first-line therapy in inflammatory bowel disease
Aliment Pharmacol Ther.
2018 Jul.
No abstract available
Comment in
-
Editorial: an argument for low-dose thiopurine allopurinol combination use as first-line therapy in inflammatory bowel disease-authors' reply.Aliment Pharmacol Ther. 2018 Jul;48(1):98-99. doi: 10.1111/apt.14798. Aliment Pharmacol Ther. 2018. PMID: 29882984 No abstract available.
Comment on
-
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).Aliment Pharmacol Ther. 2018 Apr;47(8):1092-1102. doi: 10.1111/apt.14571. Epub 2018 Feb 21. Aliment Pharmacol Ther. 2018. PMID: 29468701 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources